Latest Information

Publications

• IMB Update on Use of Antiviral Medicines for Pandemic (H1N1) 2009 Influenza (1)
• Update on National and EU Experience with the H1N1 Pandemic Vaccines
• IMB Update on Pandemic A(H1N1)v vaccines
• Drug Safety Newsletter - Special Edition Issue Number 34
• Important Safety Warning: Relenza inhalation powder must not be nebulised or administered by mechanical ventilation

Links

• The Health Protection Surveillance Centre (HPSC)
• European Medicines Agency
• The World Health Organisation

News

• European Medicines Agency maintains dosage recommendations for pandemic H1N1 vaccines
• European Medicines Agency recommends authorisation of a third vaccine for influenza pandemic (H1N1) 2009
• European Medicines Agency recommends authorisation of two vaccines for influenza pandemic (H1N1) 2009
• How to report a side-effect to a medicine used to treat or prevent the Pandemic (H1N1) 2009 flu
• Pandemic